In contrast to such “short-living” and shortly acting immunosuppressors as TGFβ, IL10, IL35, PGE2, and others produced by cancer and stromal cells, in a context-dependent fashion, intratumoral ECM is the invariably presenting and constantly acting immunosuppressive factor in TME [53,54]. Here, TGFB1 is linked to cancer.